Nisa Investment Advisors
HRMY icon

Nisa Investment Advisors’s Harmony Biosciences HRMY Stock Holding History

Nisa Investment Advisors’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.8K Buy
983
+231
+31% +$7.29K ﹤0.01% 1985
2026
Q1 		$21.1K Sell
752
-21
-3% -$689 ﹤0.01% 1983
2025
Q4 		$28.9K Buy
773
+256
+50% +$8.42K ﹤0.01% 1803
2025
Q3 		$14.2K Buy
517
+47
+10% +$1.62K ﹤0.01% 2139
2025
Q2 		$14.9K Buy
470
+290
+161% +$9.33K ﹤0.01% 2079
2025
Q1 		$5.97K Buy
180
+42
+30% +$1.51K ﹤0.01% 2209
2024
Q4 		$4.75K Sell
138
-5,422
-98% -$186K ﹤0.01% 2290
2024
Q3 		$222K Buy
5,560
+5,498
+8,868% +$193K ﹤0.01% 1254
2024
Q2 		$1.87K Buy
62
+11
+22% +$331 ﹤0.01% 2382
2024
Q1 		$1.71K Buy
51
+26
+104% +$835 ﹤0.01% 2264
2023
Q4 		$808 Sell
25
-567
-96% -$15.8K ﹤0.01% 2302
2023
Q3 		$19.4K Buy
592
+22
+4% +$764 ﹤0.01% 2030
2023
Q2 		$20.1K Buy
570
+545
+2,180% +$18.8K ﹤0.01% 2107
2023
Q1 		$1K Buy
25
+6
+32% +$273 ﹤0.01% 2394
2022
Q4 		$1K Hold
19
– – ﹤0.01% 2440
2022
Q3 		$1K Sell
19
-158
-89% -$7.71K ﹤0.01% 2438
2022
Q2 		$9K Hold
177
– – ﹤0.01% 2203
2022
Q1 		$9K Hold
177
– – ﹤0.01% 2231
2021
Q4 		$6K Sell
177
-243
-58% -$9.69K ﹤0.01% 2076
2021
Q3 		$16K Sell
420
-3,409
-89% -$110K ﹤0.01% 2136
2021
Q2 		$108K Hold
3,829
– – ﹤0.01% 1650
2021
Q1 		$127K Hold
3,829
– – ﹤0.01% 1652
2020
Q4 		$138K Buy
+3,829
New +$155K ﹤0.01% 1609

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nisa Investment Advisors's HRMY Position: Q2 2026 in Review

Nisa Investment Advisors increased its Harmony Biosciences (HRMY) stake by 31% in Q2 2026, buying an estimated $7.29K and bringing the position to 983 shares worth $35.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1985.

Nisa Investment Advisors first reported a position in HRMY in Q4 2020 and has held it in 23 quarters since. The position peaked at $222K in Q3 2024. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Nisa Investment Advisors held 983 shares of Harmony Biosciences worth $35.8K as of Q2 2026.
  • Nisa Investment Advisors bought 231 Harmony Biosciences shares in Q2 2026, an estimated $7.29K.
  • Harmony Biosciences made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1985 holding.
  • Nisa Investment Advisors first reported a position in Harmony Biosciences in Q4 2020 and has held it in 23 quarters since.
  • Nisa Investment Advisors's Harmony Biosciences position peaked at $222K in Q3 2024.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.